Predictive factors for treatment outcomes with intravitreal anti-vascular endothelial growth factor injections in diabetic macular edema in clinical practice

BACKGROUND: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections are the standard of care for diabetic macular edema (DME), a common complication of diabetes. This study aimed to identify factors influencing DME intravitreal anti-VEGF treatment outcomes in real-world practice....

Descripción completa

Detalles Bibliográficos
Autores principales: Gurung, Rajya L, FitzGerald, Liesel M, Liu, Ebony, McComish, Bennet J, Kaidonis, Georgia, Ridge, Bronwyn, Hewitt, Alex W, Vote, Brendan J, Verma, Nitin, Craig, Jamie E, Burdon, Kathryn P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074667/
https://www.ncbi.nlm.nih.gov/pubmed/37016462
http://dx.doi.org/10.1186/s40942-023-00453-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074667/
https://www.ncbi.nlm.nih.gov/pubmed/37016462
http://dx.doi.org/10.1186/s40942-023-00453-0

Ejemplares similares